NCT00620750View on ClinicalTrials.gov

Extended-release Naltrexone for Alcohol Dependence in Primary Care

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2010

Conditions
Alcohol Dependence
Interventions
DRUG

Extended release injectable naltrexone (Vivitrol)

Three sequential monthly injections of extended release injectable naltrexone (Vivitrol), with option to extend participation for an additional 12 months.

Trial Locations (1)

10016

NYU School of Medicine, New York

Sponsors

Collaborators (1)

Alkermes, Inc.
All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00620750 - Extended-release Naltrexone for Alcohol Dependence in Primary Care | Biotech Hunter | Biotech Hunter